Kevin Christal

Kevin joined CiVi Biopharma in May 2018 as vice president, operations and planning. He has more than 15 years of experience in the pharmaceutical industry, most recently as the president and chief operating officer of Eicos Sciences, a wholly-owned subsidiary of CiVi Biopharma.

Previously, Kevin spent 12 years at Actelion Pharmaceuticals, where he held various commercial leadership positions and led a number of highly successful product launches. Prior to Actelion, he was a healthcare consultant at ZS Associates and Putnam Associates.